Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Boehringer Ingelheim will build a $270 million biologics development center at its site in Biberach, Germany. The facility will combine analytical and process development with clinical-scale manufacturing, according to Fridtjof Traulsen, Boehringer’s vice president of development. It will also free up capacity for contract manufacturing. The company expects that the center, to open in 2020, will house a workforce of 500.
This article has been sent to the following recipient: